Bionano Genomics, Inc.
BNGOBionano Genomics is a life sciences instrumentation company that provides end-to-end solutions for genome analysis, specifically focusing on structural variation detection.
Table of contents
Earnings
Next report
Aug 10, 2026 (In 1 week)Competitors
By market cap
By revenue growth
Profile
Bionano Genomics is a life sciences instrumentation company that provides end-to-end solutions for genome analysis, specifically focusing on structural variation detection. The company's core value proposition is its proprietary Optical Genome Mapping (OGM) technology, which offers higher sensitivity and resolution for identifying large-scale genomic changes compared to traditional cytogenetic methods. Their ecosystem integrates specialized hardware, consumables, and platform-agnostic software to support researchers and clinicians in genetic disease and cancer research.
Bionano is a leader in the niche field of optical genome mapping, positioning itself as a digital replacement for legacy cytogenetic techniques like FISH and karyotyping.
Questions, answered.
- What is Bionano Genomics, Inc.'s market cap?
- Bionano Genomics, Inc. (BNGO) has a market capitalization of $12.4M and trades on NASDAQ.
- Who are Bionano Genomics, Inc.'s competitors?
- Bionano Genomics, Inc.'s key competitors include Illumina, Pacific Biosciences of California, Thermo Fisher Scientific, and others. These companies compete in similar markets and product categories.
- Who does Bionano Genomics, Inc. partner with?
- Bionano Genomics, Inc.'s notable partners include Illumina, Pacific Biosciences of California, Oxford Nanopore Technologies.
- What subsidiaries does Bionano Genomics, Inc. have?
- Bionano Genomics, Inc.'s subsidiaries include Lineagen, BioDiscovery, Purigen Biosystems.
- Where is Bionano Genomics, Inc. headquartered?
- Bionano Genomics, Inc. is headquartered in United States of America and employs approximately 344 people. It has been publicly traded since 2018.